T32 Publications

Khan, K., Zech, M., Morgan, A., Amor, D., Skorvanek, M., Khan, T., Hildebrand, M., Jackson, V., Scerri, T., Coleman, M., Rigbye, K., Scheffer, I., Bahlo, M., Wagner, M., Lam, D., Berutti, R., Havránková, P., Fečíková, A., Strom, T., Han, V., Dosekova, P., Gdovinova, Z., Laccone, F., Jameel, M., Mooney, M., Baig, S., Jech, R., Davis, E., Katsanis, N., Winkelmann, J. (2019). Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia. Genetics in Medicine, https://doi.org/10.1038/s41436-019-0523-0


Mooney, M., Davis, E. & Katsanis, N. (2019). Analysis of single nucleotide variants in CRISPR-Cas9 edited zebrafish embryos show no evidence of off-target inflation. BioRxiv: The preprint server for biology. https://doi.org/10.1101/568642


Stingl, C., Cardinale, K. & Van Mater, H. (2018). An Update on the Treatment of Pediatric Autoimmune Encephalitis. Current Treatment Options in Rheumatology, 4(1), 14-28. doi:10.1007/s40674-018-0089-z


Stingl, C., & Van Mater, H. (2018). Mycophenolate mofetil in the treatment of pediatric autoimmune central nervous system disease. Developmental Medicine & Child Neurology, 61, 386-392. https://doi.org/10.1111/dmcn.14098